13.000
+0,00%
2026-10-12
Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -88.4% | -102.1% | 0 / 3 | -28.5% | -12.60 pp | -11.52 pp | +1.8% | 0.02 | 44.82 | 25,6 | −28,5% | 1,4 | −77,2% | 44.82 | 6.84 | +555,2% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-12)EPS (TTM): 290,1
Financial charts
1.Revenue & growth
VND bn25,6Q2/26
1.Revenue & growth
VND bn25,6Q2/26
2.Profit & growth
VND bn0,62Q2/26
3.Profit mix (Penman)
VND bn9,20Q2/26
4.Margins & cost structure
%10.4%Q2/26
5.Returns & cash cycle
% · days-2.2%Q2/26
6.Earnings quality & cash
VND bn-9,73Q2/26
7.Asset structure
VND bn222Q2/26
8.Funding & debt health
VND bn · times222Q2/26
9.Revenue backlog
VND bn0,16Q2/26
10.Valuation
times · %42,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %43Q2/26
Adjusted EPS growth, latest quarter
-88.8%
Average adjusted EPS growth, 3 quarters
-101%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26